SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey R. Curtis, Melvin Churchill, Alan Kivitz, Ahmed Samad, Laura Gauer, Leon Gervitz, Willem Koetse, Jeffrey Melin, Yusuf Yazici, A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol, Arthritis & Rheumatology, 2015, 67, 12
  2. 2
    S Groth Madsen, B Danneskiold-Samsøe, A Stockmarr, EM Bartels, Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systematic review, Scandinavian Journal of Rheumatology, 2015, 1

    CrossRef

  3. 3
    Martin M. Crane, Maneesh Juneja, Jeffery Allen, Regina H. Kurrasch, Myron E. Chu, Emilia Quattrocchi, Stephanie C. Manson, David J. Chang, Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population, Arthritis Care & Research, 2015, 67, 12
  4. 4
    Ana-Maria Orbai, Clifton O. Bingham, Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials, Current Rheumatology Reports, 2015, 17, 4

    CrossRef

  5. 5
    Lisa Marina Li, Basile Tessier-Cloutier, Yafei Wang, Sasha Bernatsky, Evelyne Vinet, Henri André Ménard, Pantelis Panopalis, Elizabeth Hazel, Michael Stein, Martin Cohen, Michael Starr, Christian Pineau, Marie-Ève Veilleux, Inés Colmegna, Assessing Process of Care in Rheumatoid Arthritis at McGill University Hospitals, Journal of Clinical Rheumatology, 2013, 19, 4, 175

    CrossRef

  6. 6
    Stuart L. Silverman, Jeffrey Curtis, Commentary: Measuring Quality of Care in Osteoporosis, Current Osteoporosis Reports, 2013, 11, 4, 338

    CrossRef

  7. 7
    Jie Zhang, Fenglong Xie, Elizabeth Delzell, Lang Chen, Meredith L. Kilgore, Huifeng Yun, Kenneth G. Saag, James D. Lewis, Jeffrey R. Curtis, Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program, Arthritis Care & Research, 2013, 65, 11